| Dr Patrick Magnus, MD | |
|
246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301-2548 | |
| (603) 224-6070 | |
| (603) 224-6094 |
| Full Name | Dr Patrick Magnus |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 25 Years |
| Location | 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063438612 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Concord Hospital | Concord, NH | Hospital |
| Lakes Region General Hospital | Laconia, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Concord Hospital Inc | 6103721790 | 488 |
| Concord Hospital-laconia | 7012326259 | 207 |
News Archive
Despite their inclusion as essential health benefits, habilitative services face an uncertain future under the Affordable Care Act, according to a new analysis done at the George Washington University School of Public Health and Health Services.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.
Minister for Health, Social Services and Public Safety, Angela Smith MP, today welcomed the news that hospital inpatient and day case waiting lists have fallen to their lowest level for four years.
With Veterans Day approaching on November 11, our thoughts turn to supporting our veterans. Hospital for Special Care (HSC) is offering screenings for the effects of Traumatic Brain Injury (TBI) in veterans returning from service in Iraq and Afghanistan. HSC is an extensive resource to veterans and their families on the education and treatment of TBI.
› Verified 5 days ago
| Entity Name | Concord Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194778571 PECOS PAC ID: 6103721790 Enrollment ID: O20040405000916 |
News Archive
Despite their inclusion as essential health benefits, habilitative services face an uncertain future under the Affordable Care Act, according to a new analysis done at the George Washington University School of Public Health and Health Services.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.
Minister for Health, Social Services and Public Safety, Angela Smith MP, today welcomed the news that hospital inpatient and day case waiting lists have fallen to their lowest level for four years.
With Veterans Day approaching on November 11, our thoughts turn to supporting our veterans. Hospital for Special Care (HSC) is offering screenings for the effects of Traumatic Brain Injury (TBI) in veterans returning from service in Iraq and Afghanistan. HSC is an extensive resource to veterans and their families on the education and treatment of TBI.
› Verified 5 days ago
| Entity Name | Concord Hospital-laconia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053993741 PECOS PAC ID: 7012326259 Enrollment ID: O20210429001355 |
News Archive
Despite their inclusion as essential health benefits, habilitative services face an uncertain future under the Affordable Care Act, according to a new analysis done at the George Washington University School of Public Health and Health Services.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.
Minister for Health, Social Services and Public Safety, Angela Smith MP, today welcomed the news that hospital inpatient and day case waiting lists have fallen to their lowest level for four years.
With Veterans Day approaching on November 11, our thoughts turn to supporting our veterans. Hospital for Special Care (HSC) is offering screenings for the effects of Traumatic Brain Injury (TBI) in veterans returning from service in Iraq and Afghanistan. HSC is an extensive resource to veterans and their families on the education and treatment of TBI.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patrick Magnus, MD 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301-2548 Ph: (603) 224-6070 | Dr Patrick Magnus, MD 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301-2548 Ph: (603) 224-6070 |
News Archive
Despite their inclusion as essential health benefits, habilitative services face an uncertain future under the Affordable Care Act, according to a new analysis done at the George Washington University School of Public Health and Health Services.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.
Minister for Health, Social Services and Public Safety, Angela Smith MP, today welcomed the news that hospital inpatient and day case waiting lists have fallen to their lowest level for four years.
With Veterans Day approaching on November 11, our thoughts turn to supporting our veterans. Hospital for Special Care (HSC) is offering screenings for the effects of Traumatic Brain Injury (TBI) in veterans returning from service in Iraq and Afghanistan. HSC is an extensive resource to veterans and their families on the education and treatment of TBI.
› Verified 5 days ago
Patrick Cassell, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 246 Pleasant St, Suite 103, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6994 | |
Dr. Michael A Ferguson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. Clayton Theron Jones, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant St, Suite 103, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. David Scott Johnson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 253 Pleasant St, Dartmouth Hitchcock - Primary Care, Concord, NH 03301 Phone: 603-226-2200 | |
Frederick M Briccetti, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant Street, New Hampshire Oncology Hematology Pa, Concord, NH 03301 Phone: 603-224-2556 Fax: 603-226-5821 | |
Dr. Celia Ann Englander, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 281 N State St, Concord, NH 03301 Phone: 603-271-6064 |